Attached files

file filename
EX-99.2 - EXHIBIT 99.2 - China Biologic Products Holdings, Inc.exhibit99-2.htm
EX-99.1 - EXHIBIT 99.1 - China Biologic Products Holdings, Inc.exhibit99-1.htm

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of Earliest event Reported): July 11, 2011

CHINA BIOLOGIC PRODUCTS, INC.
(Exact name of registrant as specified in its charter)

Delaware 001-34566 75-2308816
(State or other jurisdiction of (Commission File No.) (IRS Employer ID No.)
incorporation or organization)    

No. 14 East Hushan Road,
Tai'an City, Shandong, 271000
People's Republic of China
(Address of Principal Executive Offices)

86-538 -620-2306
Registrant's telephone number, including area code

____________________________________________________________
(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

[  ]   Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

[  ]   Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a -12)

[  ]   Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d -2(b))

[  ]   Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e -4(c))


Item 8.01.      Other Events

On July 11, 2011, China Biologic Products, Inc. issued a press release relating to a “Plan for Guizhou Provincial Blood Collection Institutional Setting (2011-2014)” issued by the Guizhou Provincial Health Bureau and a press release relating to its opening of a plasma collection station in Shandong province. A copy of these press releases is attached hereto as Exhibit 99.1 and Exhibit 99.2 and is incorporated herein by reference.

Item 9.01      Financial Statements and Exhibits.

(d)      Exhibits

Exhibit No.   Description
     
99.1   Press Release dated July 11, 2011
99.2   Press Release dated July 11, 2011


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: July 11, 2011 CHINA BIOLOGIC PRODUCTS, INC.
   
   
  By: /s/ Chao Ming Zhao
  Chao Ming Zhao
  Chief Executive Officer


EXHIBIT INDEX

Exhibit No.   Description
     
99.1   Press Release dated July 11, 2011
99.2   Press Release dated July 11, 2011